
Sim4Flow is a healthtech company pioneering AI-driven solutions for intracranial aneurysm management. Their cloud-based platform, IRIS, uses advanced machine learning and explainable AI to analyze MRI and CT scans, providing precise, patient-specific risk assessments and treatment planning for unruptured intracranial aneurysms. This technology enables clinicians to make informed, proactive decisions to improve patient outcomes. The company recently secured €120k in pre-seed funding to expand its team, enhance technology, and broaden market reach, positioning Sim4Flow as a leader in AI-based neurovascular care innovation.

Sim4Flow is a healthtech company pioneering AI-driven solutions for intracranial aneurysm management. Their cloud-based platform, IRIS, uses advanced machine learning and explainable AI to analyze MRI and CT scans, providing precise, patient-specific risk assessments and treatment planning for unruptured intracranial aneurysms. This technology enables clinicians to make informed, proactive decisions to improve patient outcomes. The company recently secured €120k in pre-seed funding to expand its team, enhance technology, and broaden market reach, positioning Sim4Flow as a leader in AI-based neurovascular care innovation.
Sector: Healthtech (AI for neurovascular care)
Product: IRIS — cloud-based AI platform for intracranial aneurysm risk prediction
Founded: 2024 (Cyprus)
Recent funding: Pre-seed grant (~€120k) and seed round (reported €100k, Apr 1, 2025)
Team size: 3 employees (reported)
Intracranial aneurysm risk prediction and treatment planning within neurovascular diagnostics.
2024
Healthtech / Medtech
141120.00 EUR
Competitive RIF pre-seed award reported by company and profiles.
120000.00 EUR
Company announcement referenced €120k pre-seed funding to accelerate development.
100000.00 EUR
Seed round recorded on company profile with date Apr 1, 2025.
“Cyprus Research and Innovation Foundation (RIF) awarded competitive pre-seed funding”